171 related articles for article (PubMed ID: 36038420)
1. Iron-based nanoscale coordination polymers synergistically induce immunogenic ferroptosis by blocking dihydrofolate reductase for cancer immunotherapy.
Yu Y; Huang Z; Chen Q; Zhang Z; Jiang H; Gu R; Ding Y; Hu Y
Biomaterials; 2022 Sep; 288():121724. PubMed ID: 36038420
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis in antitumor therapy: Unraveling regulatory mechanisms and immunogenic potential.
Zhang T; Zeng X; Zeng E; Wang H
Int Immunopharmacol; 2024 Jun; 134():112203. PubMed ID: 38705030
[TBL] [Abstract][Full Text] [Related]
3. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.
Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X
J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis is an effective strategy for cancer therapy.
Khan A; Huo Y; Guo Y; Shi J; Hou Y
Med Oncol; 2024 Apr; 41(5):124. PubMed ID: 38652406
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer.
Ding Q; Tang W; Li X; Ding Y; Chen X; Cao W; Wang X; Mo W; Su Z; Zhang Q; Guo H
J Control Release; 2023 Nov; 363():221-234. PubMed ID: 37717657
[TBL] [Abstract][Full Text] [Related]
6. The new era of lung cancer therapy: Combining immunotherapy with ferroptosis.
Li Y; Tuerxun H; Zhao Y; Liu X; Li X; Wen S; Zhao Y
Crit Rev Oncol Hematol; 2024 Jun; 198():104359. PubMed ID: 38615871
[TBL] [Abstract][Full Text] [Related]
7. Copper-Based Nanoscale Coordination Polymers Augmented Tumor Radioimmunotherapy for Immunogenic Cell Death Induction and T-Cell Infiltration.
Wang Y; Ding Y; Yao D; Dong H; Ji C; Wu J; Hu Y; Yuan A
Small; 2021 Feb; 17(8):e2006231. PubMed ID: 33522120
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
[TBL] [Abstract][Full Text] [Related]
10. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
11. Transformable Supramolecular Self-Assembled Peptides for Cascade Self-Enhanced Ferroptosis Primed Cancer Immunotherapy.
Wang H; Jiao D; Feng D; Liu Q; Huang Y; Hou J; Ding D; Zhang W
Adv Mater; 2024 May; 36(21):e2311733. PubMed ID: 38339920
[TBL] [Abstract][Full Text] [Related]
12. A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy.
Wang Y; Chen Q; Song H; Zhang Y; Chen H; Liu P; Sun T; Jiang C
Small; 2022 Oct; 18(41):e2201704. PubMed ID: 36071027
[TBL] [Abstract][Full Text] [Related]
13. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment.
Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC
Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872
[TBL] [Abstract][Full Text] [Related]
14. A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy.
Yang Q; Liu T; Zheng H; Zhou Z; Huang Y; Jia H; Fu S; Zhang X; Zhang H; Liu Y; Chen X; Shan W
Biomaterials; 2023 Jan; 292():121936. PubMed ID: 36502663
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible Polymer-Modified Nanoplatform for Ferroptosis-Enhanced Combination Cancer Therapy.
He M; Dan Y; Chen M; Dong CM
Macromol Biosci; 2023 Nov; 23(11):e2300215. PubMed ID: 37363952
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy.
Liu P; Lin C; Liu Z; Zhu C; Lin Z; Xu D; Chen J; Huang Q; Li CY; Hou L; Pan JA; Liu X
Cell Mol Life Sci; 2022 Jun; 79(7):352. PubMed ID: 35676564
[TBL] [Abstract][Full Text] [Related]
17. Dual-enzyme decorated semiconducting polymer nanoagents for second near-infrared photoactivatable ferroptosis-immunotherapy.
Liu Y; Lu R; Li M; Cheng D; Wang F; Ouyang X; Zhang Y; Zhang Q; Li J; Peng S
Mater Horiz; 2024 May; 11(10):2406-2419. PubMed ID: 38440840
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy.
Han W; Duan X; Ni K; Li Y; Chan C; Lin W
Biomaterials; 2022 Jan; 280():121315. PubMed ID: 34920370
[TBL] [Abstract][Full Text] [Related]
19. A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy.
Fan F; Liu P; Bao R; Chen J; Zhou M; Mo Z; Ma Y; Liu H; Zhou Y; Cai X; Qian C; Liu X
Cancer Res; 2021 Dec; 81(24):6233-6245. PubMed ID: 34711611
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment.
Huang Z; Yao D; Ye Q; Jiang H; Gu R; Ji C; Wu J; Hu Y; Yuan A
ACS Nano; 2021 May; 15(5):8450-8465. PubMed ID: 33938751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
